Contact

  • Benu BioPharma

  • Dennis Goldberg, Ph.D., FAHA

  • Partner
  • dgoldberg@benubio.com
  • Eric M. Morrel, Ph.D.

  • VP Clinical Research
  • emorrel@benubio.com

News and Events

May 7, 2018

LIPIMETIX DEVELOPMENT ANNOUNCES SUB-LICENSE OF APO E MIMETIC PEPTIDE PLATFORM TO ANJI PHARMA, CHINA
>> Read More

November 14, 2017

eXIthera Presents Clinical Data on Novel Small Molecule FXIa Inhibitor EP-7041 at American Heart Association
>> Read More

December 19, 2016

Capstone Therapeutics Announces Profound, Rapid LDL Cholesterol Reduction in AEM-28-14 Primate Study
>> Read More

Aug. 25, 2016

Capstone Therapeutics Announces That Its Joint Venture, LipimetiX Development, Inc.
>> Read More

Feb. 03, 2016

Capstone Therapeutics Announces Existing Shareholder Decision Not to Extend Exclusive due Diligence Period Other OTC_CAPS
>> Read More

Dec. 15, 2015

Capstone Therapeutics Announces Loan From Existing Shareholder for Exclusive Due Diligence Period Other OTC_CAPS
>> Read More

Oct. 14, 2015

Capstone Therapeutics Announces Allowance of U.S Patent for Treatment of Diabetes with Apo E Mimetic Peptides
>> Read More